SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division […]
Proteona leads international consortium to develop SARS-CoV-2 neutralizing antibody to help vulnerable immunocompromised individuals Innovative AI-driven proteogenomic analysis company applies single cell analysis expertise to developing treatments for COVID-19 The Proteona team is leveraging on its ESCAPE™ single cell proteogenomics platform to discover SARS-CoV-2 neutralizing antibodies. Singapore, 25 March 2020 – Proteona Pte. Ltd. and partners […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today shared news from clinical partners on the use of the ProteinSimple-branded Ella Automated Immunoassay platform in the fight against COVID-19. In a March 23, 2020 press release, the Icahn School of Medicine, Mount Sinai announced that they are utilizing Bio-Techne’s Ella Automated Immunoassay Platform to monitor individual immune responses […]
BALTIMORE, MD – PathSensors Inc, a Baltimore biotechnology company, announced today that they are developing a CANARY biosensor to detect the Novel SARS Coronavirus (SARS-CoV-2), the causal agent for the coronavirus disease COVID–19. The biosensor will be available for research purposes in May 2020 and validation data on the new SARS-CoV-2 product will be available […]
Genovis’ Nomination Committee proposes new election of Torben Jørgensen to serve on the Board of Directors and as Chairman of the Board at the Annual General Meeting on May 5. Torben Jørgensen was born in 1952 and is currently Chairman of the Board of Biotage AB and Atlas Antibodies AB. He also serves on the […]
AMSBIO announce the availability of recombinant proteins and antibodies for detection of Coronavirus (COVID-19) and related RNA viruses. Historically strains of Coronavirus able to infect humans (HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoVHKU1) were not highly pathogenic and only caused mild respiratory illness. By comparison more recent strains – SARS-CoV, MERS-CoV and COVID-19 that emerged in Wuhan, China at the end of […]
Uppsala, Sweden: Gyros Protein Technologies AB, a Mesa Laboratories, Inc. (NASDAQ:MLAB) company, and pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and the Jefferson Institute for Bioprocessing (JIB) at Thomas Jefferson University, a leading center of excellence providing advanced training to the bioprocessing industry, today announced that Gyrolab xPlore™ immunoassay system from Gyros Protein Technologies will […]
Sengenics, a leading precision medicine company, today announced that the company has made full-length, correctly folded and functional COVID-19 antigens available for purchase for both research and vaccine development purposes. Sengenics has successfully expressed these antigens using the company’s patented and validated KREX™ technology. ”The surge of COVID-19 infections has pushed us to accelerate the production […]
Firms to link platforms to supercharge biopharmaceutical quality monitoring capabilities NEWARK, Calif. and CUPERTINO, Calif. — Intabio, Inc. and Protein Metrics Inc., developers of advanced analytical tools for accelerating biopharmaceutical development and manufacturing, today announced a co-development and co-marketing agreement to couple Intabio’s Blaze™ instrument system with the Byos® software suite from Protein Metrics. The integrated Blaze-Byos platform […]
SAN JOSE, Calif. — ForteBio, the Biologics Business Unit of Molecular Devices, today announced that to aid in the discovery of human therapeutic antibodies to viral infections like dengue fever and eastern equine encephalitis, the Vanderbilt Vaccine Center recently became one of the first academic institutes in North America to adopt ForteBio’s Octet HTX system. A centerpiece in the Biopharm […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
